Robert Shumaker is an experienced professional in the field of clinical pharmacology and translational medicine, currently serving as Executive Director at Eisai US since 2008. Previously held the position of Senior Director in Clinical Pharmacology at Eisai US as well. Robert's career includes roles as Director of Biopharmaceutics at Sandoz and Ivax, as well as Senior Director of Clinical Affairs at Alpharma. Earlier in Robert's career, significant contributions were made as Director of Clinical Pharmacology at Wallace Laboratories and as a Senior Research Pharmacokineticist II at Merrell Dow Research Institute. The academic background includes a PhD and MSc in Pathology from the University of Wisconsin-Madison, and a BSc in Microbiology from The Ohio State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices